Nov 9 (Reuters) - Trading volumes in the 30 minutes after the first successful data from a large-scale clinical trial of a coronavirus vaccine were up to 10 times the level seen earlier in the day, an IG spokesman told Reuters on Monday.
The levels, which the spokesman called “unprecedented”, broke a previous record set in March when markets recorded sharp falls at the peak of virus-related restrictions. (Reporting by Muvija M in Bengaluru Editing by Rachel Armstrong)
Reuters Breakingviews is the world's leading source of agenda-setting financial insight. As the Reuters brand for financial commentary, we dissect the big business and economic stories as they break around the world every day. A global team of about 30 correspondents in New York, London, Hong Kong and other major cities provides expert analysis in real time.
Sign up for a free trial of our full service at https://www.breakingviews.com/trial and follow us on Twitter @Breakingviews and at www.breakingviews.com. All opinions expressed are those of the authors.